Oncology
2290 articles · 70 journals
Journals in this subcategory (70)
- EJC Skin Cancer · Elsevier (91)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (90)
- Blood Neoplasia · Elsevier (90)
- The Lancet Oncology · Elsevier (89)
- Cancer Treatment and Research Communications · Elsevier (85)
- European Journal of Surgical Oncology · Elsevier (85)
- Journal of Thoracic Oncology · Elsevier (83)
- Brachytherapy · Elsevier (81)
- Cancer Epidemiology · Elsevier (81)
- International Journal of Gynecological Cancer · Elsevier (80)
- Asia-Pacific Journal of Clinical Oncology · Wiley (72)
- Lung Cancer · Elsevier (69)
- European Journal of Cancer · Elsevier (68)
- Critical Reviews in Oncology/Hematology · Elsevier (67)
- Leukemia Research Reports · Elsevier (66)
- Surgical Oncology Clinics of North America · Elsevier (66)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (64)
- Gynecologic Oncology Reports · Elsevier (62)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (58)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (54)
- The Journal of Liquid Biopsy · Elsevier (53)
- Leukemia Research · Elsevier (52)
- Cancer Letters · Elsevier (51)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (39)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Current Problems in Cancer: Case Reports · Elsevier (30)
- Journal of Geriatric Oncology · Elsevier (30)
- Journal of Bone Oncology · Elsevier (29)
- Intelligent Oncology · Elsevier (20)
- Precision Radiation Oncology · Wiley (20)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- Best Practice & Research Clinical Haematology · Elsevier (12)
- npj Precision Oncology · Springer Nature (12)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- British Journal of Cancer · Springer Nature (8)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- The role of lymph node dissection in upper tract urothelial carcinoma
- Androgen deprivation drives prostate cancer cells into a glycolysis-coupled senescence-like state
- 2026 World Conference on Lung Cancer
- Kenya agrees major cuts to cancer drug prices
- Toxic dust around the World Trade Center
- Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial
- Global burden of cancer attributable to infections in 2024: a worldwide incidence analysis
- Defining Operability and Resectability of Retroperitoneal Sarcomas
- Retroperitoneal Sarcoma: Integrating Histologic Subtype into Modern Multimodal Treatment Paradigms
- Thoracic Surgical Paradigms for Sarcoma of the Chest, Lung, and Mediastinum
- Immune Checkpoint Inhibitors in Advanced Soft Tissue Sarcomas: Current Role, Clinical Evidence, and Future Directions
- Genitourinary Sarcomas: A Practical Update for the Urologic Oncologist
- Characterization of the genomic and transcriptomic landscape of invasive non-mucinous lung adenocarcinoma based on IASLC grading
- Reassessing surgical resection in small cell lung cancer in the multimodal treatment era
- Discordance in pleural mesothelioma response classification and modelling of impact on clinical trials
- Systemic therapy and radiotherapy for small-cell lung cancer brain metastases
- Cardiovascular outcomes and mortality risk associated with GLP-1 RAs vs. SGLT-2 inhibitors in patients with incident lung cancer: A target trial emulation
- Lymph Node Pathologic Grading Strategy: Under the Backdrop of the IASLC Grading System for Invasive Lung Adenocarcinoma – A Retrospective Cohort Study Among Asian Patients
- Adjuvant Osimertinib in Resected EGFR-Mutated Stage IB–IIIA NSCLC: Exploratory 8-Year Overall Survival Landmark Update from the ADAURA Trial
- Integrated Multi-Omic Profiling Enables Recurrence Risk Stratification Beyond Pathological Stage in Resected EGFR-Mutant Lung Adenocarcinoma
- Genomic and Transcriptomic Features of Relapsed SCLC
- Final Biomarker and Efficacy Analyses of Lorlatinib in Patients With ALK-Positive Advanced NSCLC in a Phase 2 Study
- A pilot randomized controlled trial of the feasibility and safety of a combined Epigallocatechin-3-gallate (EGCG) and vitamin C nutraceutical in pre-frail and frail older cancer survivors: Results from the ReFOCUS1 trial
- Vaginal natural orifice transluminal endoscopic surgery versus conventional laparoscopy for sentinel lymph node mapping in early-stage endometrial cancer: a systematic review and meta-analysis
- Somatic BRCA1 and BRCA2 detection in homologous recombination deficiency testing: concordance of four sequencing workflows with the Myriad myChoice companion diagnostic
- Longitudinal kinetics of human epididymis protein 4 in recurrent advanced ovarian carcinoma treated with platinum-based chemotherapy: mathematical modeling and prognostic implications
- Mortality trends and disparities in ovarian cancer among women aged 45 years and older in the United States, 1999-2020: a CDC WONDER analysis
- Treatment and outcome of elderly patients with presumed early ovarian cancer in Germany: real-world observations from the quality-assurance program of the AGO Study Group
- Exploratory analysis of non-hematopoietic circulating cancer-related cells in women with complex adnexal masses: translational findings from MIRRORS-FROZEN (a feasibility pilot randomised controlled trial comparing open versus robotic surgery in the management of women with complex pelvic adnexal masses ≤8 cm)
- Response to Letter to the Editor: “NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial”